HIV trial shows injectable prevents 100% infection in women and girls
|
Gilead's injectable drug is a potential game changer in
efforts to curb HIV infections, according to health experts who are
calling on the ... |
New strategy targets rare B cells for effective HIV vaccine development
... epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus ( HIV ). View article...